Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Monday, February 03, 2025. Let’s ...
Zacks.com on MSN4h
Should You Invest in the SPDR S&P Biotech ETF (XBI)?The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the U.S. common stocks listed on the NYSE, AMEX, ...
The microplate reader market is projected to grow from USD 605.2 million in 2023 to USD 916.8 million by 2031, driven by ...
TipRanks on MSN2d
Nautilus Biotechnology Announces Board Member DeparturesNautilus Biotechnolgy ( ($NAUT) ) has shared an update. On January 27 and 28, 2025, Vijay Pande and Michael Altman informed ...
Vir Biotechnology, Inc., a $1.5 billion market cap biotech company, announced a change in its executive team with the upcoming departure of Ann (Aine) M. Hanly, Ph.D., and the appointment of Maninder ...
Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.
To stay up to date on Akari's recent developments on the Webull Corporate Connect Services Platform, current Webull users can ...
The healthcare industry is set for growth due to advancements in targeted treatments and personalized care and the rapid ...
引言基因治疗为许多遗传性疾病提供了治愈的希望。肝脏作为人体重要的代谢器官，一直是基因治疗研究的重点之一。肝脏基因治疗不仅可以治疗许多与肝脏相关的遗传性疾病，如血友病和高氨血症等，而且具有极大的临床应用潜力。然而，尽管腺相关病毒（AAV，Adeno-Associated ...
Scientists have completed construction of the final chromosome in the worlds' first synthetic yeast genome following more than a decade of work, opening new possibilities for creating resilient, ...
旧金山 - 市值15亿美元的生物科技公司Vir Biotechnology, Inc.宣布其高管团队将发生变动，Ann (Aine) M. Hanly博士即将离职，Maninder Hora博士将被任命为新的执行副总裁兼首席技术运营官。根据 InvestingPro 的数据，该公司保持着8.94倍的强劲流动比率，尽管面临快速现金消耗的挑战。
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback